Concepedia

Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug resistance modifiers

Hirotaka Matsui, Akihiro Takeshita, Kensuke Naito, Kaori Shinjo, Kohichiro Shigeno, Masato Maekawa, Yoshinori Yamakawa, M Tanimoto, Miki Kobayashi, Kazunori Ohnishi,

Leukemia · 2002 · 104 citations · 47 references

DOI

Concepts

References

47

Proposed Revised Criteria for the Classification of Acute Myeloid Leukemia

John M. Bennett · Annals of Internal Medicine · 1985 · 3K citations

, , +8

Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell

Masatake Osawa, Ken‐ichi Hanada, Hirofumi Hamada et al. · Science · 1996 · 2.1K citations

, , +17

AC133, a Novel Marker for Human Hematopoietic Stem and Progenitor Cells

Amy H. Yin, Sheri Miraglia, Esmail D. Zanjani et al. · Blood · 1997 · 1.8K citations · Full text

, , +13

Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse

Eric L. Sievers, Richard A. Larson, Edward A. Stadtmauer et al. · Journal of Clinical Oncology · 2001 · 893 citations

, , +17

CD34: structure, biology, and clinical utility [see comments]

Krause Ds, MJ Fackler, CI Civin et al. · Blood · 1996 · 876 citations

, , +7